Krichevsky, Anna M.
Uhlmann, Erik J.
Funding for this research was provided by:
National Institutes of Health (R01 CA215072)
National Institute of Neurological Disorders and Stroke (R21 NS098051)
National Institutes of Health (U19 CA179563)
This article is maintained by: Elsevier
Article Title: Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-018-00702-3
Content Type: article
Copyright: Copyright © 2019 The authors. Published by Elsevier B.V. All rights reserved.